Drug Delivery

Mice Inoculated with Hepatitis B Tagged Microspheres Show Good Immune Response

Published in Hepatitis Weekly, February 12th, 2001

- Sonia Nichols, staff medical writer -- Tiny microspheres embedded with hepatitis B surface antigen (HBsAg) may comprise the next generation of drug delivery systems for hepatitis B vaccines, if the latest research being developed in bioengineering labs pans out.

Several research institutions have already delved into the use of these microspheres as adjuvant drug delivery mechanisms for a number of pharmaceuticals. One of the latest studies, performed in the Department of Biotechnological Engineering at Ben Gurion University of Negev, has tested the use of these HBsAg entrapped microscopic orbs on mice.

The group used two sizes of microencapsulated...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-02-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry